mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.009 |
mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.096 |
0.01 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.01 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.088 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.01 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.02 |
mRNA |
elocalcitol |
CTRPv2 |
pan-cancer |
AAC |
-0.084 |
0.02 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.071 |
0.02 |